Women's health isn't a cause, it's infrastructure. Med tech founder Marissa Fayer breaks down why closing the women's health gap is worth a trillion dollars a year, and why capital still isn't following.
In this conversation:
- Why dense breast tissue affects up to 70% of women, and how software can cut repeat scans
- Why only about 6% of private healthcare capital goes to conditions that affect women
- How menopause and perimenopause hit during women's most productive career years, and what employers get wrong
- Why the women's health market is mispriced, not unproven
- How the funding conversation looks different across the US, Africa, and Asia
***Marissa Fayer, CEO, DeepLook Medical***
***Megan Antonelli, Chief Executive Officer, HealthIMPACT Live***
Subscribe to Digital Health Talks on Apple Podcasts, Spotify, YouTube, or wherever you listen.
Learn more about HealthIMPACT Live events, virtual forums, and healthcare leader conversations at healthimpactlive.com.
Interested in being a guest, sponsoring, or joining the HealthIMPACT community? Visit healthimpactlive.com/digital-health-talks.
Marissa FayerGuest
Megan AntonelliHost